SummaryFoshan JIALIANDA Medical Apparatus Co., Ltd. is a China-based factory established in 2012, specializing in ENT treatment units, patient chairs, dental chairs, endoscopes, and related medical equipment. It operates a 5,000 m² manufacturing plant with three production lines and 6–10 quality-control staff. The company reports exports through direct and agent channels, with markets in Africa, Southeast Asia/Mideast, and Europe, and states that its products have reached more than 200 countries and areas. It holds a business license, medical device registration certificate, production license, and CE certification according to the provided information. Evidence supports manufacturing capability, quality-control processes, export experience, and stated after-sales service. However, the slices provide insufficient detail to assess financial credibility, customization capability, or specific customer cases. Innovation evidence is present but limited, including one year of R&D engineer experience and references to...
Supplier typeThe supplier is identified as a factory and limited company based in Foshan, Guangdong, China. It is described as a high-tech manufacturer established in 2012, specializing in developing, producing, and marketing ENT treatment units, patient chairs, dental chairs, and related equipment.
CertificationsThe supplier states that it has a business license, medical device registration certificate, production license, and CE certification. These are explicit certification and regulatory-document claims, although no certificate numbers, issuing bodies, or validity dates are provided.
After-Sales capabilityThe company explicitly promotes after-sales service and states that every ENT unit and electric patient chair is inspected before delivery. This supports a stated service and pre-delivery quality approach, but the slices do not describe service personnel, response times, warranty terms, or spare-parts support.
Production capacityThe supplier reports a 5,000 m² manufacturing plant, three production lines, 6–10 quality-control staff, and one-month lead times in both off-peak and peak seasons. Its product specialization and stated inspection before delivery further support operational production capability.